Thus, in many advanced-stage tumours, TGF-β signalling is diverted away from suppressing cell proliferation and instead activates a cellular programme called epithelial-mesenchymal transition (EMT), which confers cancer cells with mesenchymal cell traits, increasing their motility and favouring invasion [184,185]. This evidence concerns the gene TGFB1 and cancer.